Stock 300119 TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianjin Ringpu Bio-Technology Co.,Ltd.

Equities

300119

CNE100000TV1

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
17.99 CNY +5.70% Intraday chart for Tianjin Ringpu Bio-Technology Co.,Ltd. +9.76% +9.76%
Apr. 29 Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership). CI
Apr. 25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.

Number of employees: 2,496

Sales per Business

CNY in Million2022Weight2023Weight Delta
Preparations and APIs
48.2 %
975 46.8 % 1,084 48.2 % +11.20%
Poultry Biological Products
41.3 %
896 43.0 % 928 41.3 % +3.64%
Animal Biological Products
6.3 %
130 6.2 % 141 6.3 % +8.47%
Other
2.9 %
34 1.7 % 66 2.9 % +91.12%
Pet Medicines
1.2 %
44 2.1 % 27 1.2 % -39.72%
Pet Biological Products
0.2 %
6 0.3 % 4 0.2 % -33.42%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
2,084 100.0 % 2,249 100.0 % +7.90%

Managers

Managers TitleAgeSince
Shou Jun Li CEO
 Chief Executive Officer 61 98-08-02
Chang Chang Li DFI
 Director of Finance/CFO 49 22-04-27
Xiu Tong Zhu BRD
 Director/Board Member 43 20-10-26
Ai Ling Liu BRD
 Director/Board Member 49 18-12-23
Lei Xu BRD
 Director/Board Member 51 19-12-24
Wen Yu Zhao IRC
 Investor Relations Contact 32 22-09-12
Gang Xie SEC
 Corporate Secretary 39 22-08-10

Members of the board

Members of the board TitleAgeSince
Shou Jun Li CEO
 Chief Executive Officer 61 98-08-02
Zhong Hua Zhou CHM
 Chairman 61 18-12-23
Lei Xu BRD
 Director/Board Member 51 19-12-24
Ai Ling Liu BRD
 Director/Board Member 49 18-12-23
Rui Li BRD
 Director/Board Member 35 18-12-20
Rui Zhou BRD
 Director/Board Member 53 18-12-20
Xiu Tong Zhu BRD
 Director/Board Member 43 20-10-26
Juan Yang BRD
 Director/Board Member 49 22-09-12
Xue Peng Cai BRD
 Director/Board Member 66 22-09-12
Fei Liang BRD
 Director/Board Member 40 23-03-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 466,276,186 127,499,010 ( 27.34 %) 8,898,350 ( 1.908 %) 27.34 %

Shareholders

NameEquities%Valuation
Shou Jun Li
12.85 %
41,868,620 12.85 % 84 M ¥
GF Fund Management Co., Ltd.
11.31 %
36,855,627 11.31 % 74 M ¥
Wu Liang
7.279 %
23,716,898 7.279 % 47 M ¥
En Dong Bao
3.427 %
11,165,454 3.427 % 22 M ¥
Dalai Suyala
3.369 %
10,977,595 3.369 % 22 M ¥
Zhen Zhang
1.697 %
5,530,774 1.697 % 11 M ¥
Guotai Asset Management Co., Ltd.
1.585 %
5,163,717 1.585 % 10 M ¥
Truvalue Asset Management Co. Ltd.
1.541 %
5,019,742 1.541 % 10 M ¥
Shanghai Anything Investment Co., Ltd.
1.056 %
3,440,000 1.056 % 7 M ¥
Turing Private Equity Fund Management Hainan Co. Ltd.
1.013 %
3,302,000 1.013 % 7 M ¥
NameEquities%Valuation
Shou Jun Li
95.18 %
125,605,859 95.18 % 251 M ¥

Company contact information

Tianjin Ringpu Bio-technology Co., Ltd.

1 Dongjiu Road Tianjin Airport Economic Zone

300308, Tianjin

+

http://www.ringpu.com
address Tianjin Ringpu Bio-Technology Co.,Ltd.(300119)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Veterinary Drugs

Sales per Business

Ratings for Tianjin Ringpu Bio-Technology Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
17.99 CNY
Average target price
21.14 CNY
Spread / Average Target
+17.49%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

1st Jan change Capi.
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
+9.76% 1.09B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+11.95% 6.66B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+26.88% 3.78B
VIRBAC Stock Virbac
-0.42% 3.14B
VIMIAN GROUP AB Stock Vimian Group AB
+9.80% 1.59B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-11.98% 1.43B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-23.69% 1.28B
VETOQUINOL SA Stock Vetoquinol SA
-7.23% 1.22B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-7.75% 1.2B
PULIKE BIOLOGICAL ENGINEERING, INC. Stock Pulike Biological Engineering, Inc.
-18.23% 829M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. 300119 Stock
  4. Company Tianjin Ringpu Bio-Technology Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW